News & Views | Published:

Cardiac regenerative medicine 2.0

Nature Biotechnology volume 31, pages 209211 (2013) | Download Citation

The key challenge in the field of molecular and cell-based therapies for heart regeneration is controlled delivery.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , & Lancet 379, 933–942 (2012).

  2. 2.

    et al. Nature 492, 376–381 (2012).

  3. 3.

    et al. Circ. Res. 110, 1465–1473 (2012).

  4. 4.

    et al. Nature 476, 228–231 (2011).

  5. 5.

    & Cardiovasc. Res. 83, 179–194 (2009).

  6. 6.

    & Am. J. Physiol. Heart Circ. Physiol. 303, H501–H512 (2012).

  7. 7.

    , , , & Nature 432, 466–472 (2004).

  8. 8.

    et al. Science 338, 1599–1603 (2012).

  9. 9.

    et al. Nature 485, 599–604 (2012).

  10. 10.

    et al. Nature 485, 593–598 (2012).

Download references

Author information

Affiliations

  1. Boon-Seng Soh, Hao Wu and Kenneth R. Chien are in the Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA.

    • Boon-Seng Soh
    • , Hao Wu
    •  & Kenneth R Chien
  2. Department of Cell and Molecular Biology and Medicine, Karolinska Institute, Stockholm, Sweden.

    • Kenneth R Chien

Authors

  1. Search for Boon-Seng Soh in:

  2. Search for Hao Wu in:

  3. Search for Kenneth R Chien in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Kenneth R Chien.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.2524

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing